The federal government has negotiated a series of agreements with major pharmaceutical companies to offer certain drugs at dramatically reduced prices to U.S. consumers.
The agreements resulted from President Donald Trump’s Most Favored Nation prescription price policy, initiated in May, which asked drugmakers to offer their lowest prices in the United States voluntarily.
These agreements are structured on four points outlined by the White House. A senior administration official said on Oct. 16 that each of the deals includes these items, though not all details have been made public.
Drug prices in the United States are at least twice as high as those anywhere else in the world, according to a 2024 report from the Department of Health and Human Services. For the most expensive medications, the disparity is even greater….